Literature DB >> 2424342

Ketanserin in the preoperative and intraoperative management of a patient with carcinoid tumor undergoing tricuspid valve replacement.

P A Casthely, M Jablons, R B Griepp, M A Ergin, K Goodman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2424342

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  4 in total

Review 1.  Carcinoid heart disease: presentation, diagnosis, and management.

Authors:  David J Fox; Rajdeep S Khattar
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

Review 2.  Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

3.  The prophylactic use of octreotide in a patient with ovarian carcinoid and valvular heart disease.

Authors:  J T Watson; N H Badner; M J Ali
Journal:  Can J Anaesth       Date:  1990-10       Impact factor: 5.063

Review 4.  Carcinoid syndrome and serotonin: therapeutic effects of ketanserin.

Authors:  J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.